SCHEMBL12256397

SCHEMBL12256397

CC(F)(F)S(=O)(=O)N(C1CCCCC1)C1CCCCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1A P07327 4/20 0.35
ADH1C P00326 3/20 0.35
ADH1B P00325 1/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HSD11B1 P28845 4/20 0.33
NPSR1 Q6W5P4 1/20 0.31
TLR8 Q9NR97 1/20 0.31
USP2 O75604 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31
PDK4 Q16654 1/20 0.31
HTT P42858 1/20 0.30
MCOLN3 Q8TDD5 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7856508 0.83 ADH1A (0.33) ADH1AADH1CADH1BMEN1KMT2A
SCHEMBL13605168 0.83 ADH1A (0.38) ADH1AADH1CADH1BMEN1KMT2A
SCHEMBL12452688 0.81 ADH1C (0.32) ADH1AADH1CADH1BMEN1KMT2A
SCHEMBL13605169 0.80 ADH1A (0.34) ADH1AADH1CADH1BMEN1KMT2A
SCHEMBL9609283 0.76 NPSR1 (0.30) NPSR1
SCHEMBL14195509 0.76 ADH1A (0.37) ADH1AADH1CADH1BMEN1KMT2A
SCHEMBL16519687 0.75 NPSR1 (0.35) ADH1AADH1CADH1BMEN1KMT2A
SCHEMBL14606233 0.74 ALDH1A1 (0.35) ADH1AADH1CADH1BMEN1KMT2A
SCHEMBL14144421 0.73 ADH1A (0.34) ADH1AADH1CADH1BUSP2HPGD
SCHEMBL18572499 0.73 ADH1B (0.32) ADH1AADH1CADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8709704-B2 Pattern forming method using developer containing organic solvent and rinsing solution for use in the pattern forming method FUJIFILM CORPORATION (JP) 2014-04-29 US disclosed
US-20110229832-A1 PATTERN FORMING METHOD USING DEVELOPER CONTAINING ORGANIC SOLVENT AND RINSING SOLUTION FOR USE IN THE PATTERN FORMING METHOD FUJIFILM CORPORATION (JP) 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110229832-A1 PATTERN FORMING METHOD USING DEVELOPER CONTAINING ORGANIC SOLVENT AND RINSING SOLUTION FOR USE IN THE PATTERN FORMING METHOD RER1, RARA, RARG ADH1A 731/4885ADH1C 683/4885ADH1B 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.